Insider trading

Period: 120 months Stock: ALEC + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

180 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

180 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

180 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

180 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
180 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
180 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

180 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
4 Mar 2024
Kenkare-Mitra Sara President and Head of R&D
Sold at will
$70.39K 10,169 at 6.92
3.1%
Not planned
4 Mar 2024
Romano Gary Chief Medical Officer
Sold at will
$41.55K 6,001 at 6.92
3.0%
Not planned
4 Mar 2024
GRASSO MARC Chief Financial Officer
Sold at will
$39.56K 5,716 at 6.92
3.8%
Not planned
4 Dec 2023
Rosenthal Arnon Chief Executive Officer
Sold at will
$132.50K 23,831 at 5.56
1.2%
Not planned
4 Dec 2023
Kenkare-Mitra Sara President and Head of R&D
Sold at will
$69.61K 12,519 at 5.56
3.7%
Not planned
4 Dec 2023
Romano Gary Chief Medical Officer
Sold at will
$27.99K 5,035 at 5.56
2.4%
Not planned
4 Dec 2023
GRASSO MARC Chief Financial Officer
Sold at will
$25.43K 4,574 at 5.56
2.9%
Not planned
11 Sep 2023
Sold at will
$3.00M 500,000 at 6.00
4.4%
Not planned
11 Sep 2023
MCGUIRE TERRANCE Director · indirect
Sold at will
$3.00M 500,000 at 6.00
4.4%
Not planned
5 Sep 2023
Kenkare-Mitra Sara President and Head of R&D
Sold at will
$32.28K 6,214 at 5.19
3.4%
Not planned
5 Sep 2023
Rosenthal Arnon Chief Executive Officer
Sold at will
$29.33K 5,647 at 5.19
0.3%
Not planned
5 Sep 2023
Romano Gary Chief Medical Officer
Sold at will
$14.39K 2,771 at 5.19
2.7%
Not planned
5 Sep 2023
GRASSO MARC Chief Financial Officer
Sold at will
$5.79K 1,114 at 5.19
3.3%
Not planned
2 Jun 2023
Rosenthal Arnon Chief Executive Officer
Sold at will
$36.28K 5,255 at 6.90
0.3%
Not planned
2 Jun 2023
Kenkare-Mitra Sara President and Head of R&D
Sold at will
$28.25K 4,092 at 6.90
2.2%
Not planned
2 Jun 2023
Romano Gary Chief Medical Officer
Sold at will
$18.07K 2,617 at 6.90
2.5%
Not planned
2 Jun 2023
GRASSO MARC Chief Financial Officer
Sold at will
$7.25K 1,050 at 6.90
3.1%
Not planned
17 Mar 2023
Rosenthal Arnon Chief Executive Officer
Sold at will
$94.43K 15,186 at 6.22
0.9%
Not planned
2 Mar 2023
Kenkare-Mitra Sara President and Head of R&D
Sold, plan not stated
$84.22K 10,124 at 8.32
5.1%
2 Mar 2023
Rosenthal Arnon Chief Executive Officer
Sold, plan not stated
$48.65K 5,849 at 8.32
0.4%
2 Mar 2023
Romano Gary Chief Medical Officer
Sold, plan not stated
$26.93K 3,238 at 8.32
3.0%
2 Mar 2023
GRASSO MARC Chief Financial Officer
Sold, plan not stated
$10.74K 1,291 at 8.32
3.6%
2 Dec 2022
Romano Gary Chief Medical Officer
Sold, plan not stated
$18.68K 2,145 at 8.71
1.9%
2 Sep 2022
Romano Gary Chief Medical Officer
Sold, plan not stated
$23.12K 2,177 at 10.62
2.4%
2 Sep 2022
King Robert Chief Development Officer
Sold, plan not stated
$1.87K 176 at 10.62
0.0%
2 Jun 2022
King Robert Chief Development Officer
Sold, plan not stated
$1.54K 177 at 8.71
0.0%
1 Mar 2022
King Robert Chief Development Officer
Sold, plan not stated
$4.47K 287 at 15.57
0.1%
13 Dec 2021
SULIMAN SHEHNAAZ President and COO
Sold, plan not stated 2×
$1.59M 75,000 at 21.24
42.2%
10 Dec 2021
SULIMAN SHEHNAAZ President and COO
Sold, plan not stated 2×
$1.63M 75,000 at 21.76
42.2%
9 Dec 2021
SULIMAN SHEHNAAZ President and COO
Sold, plan not stated 2×
$1.71M 75,000 at 22.82
42.2%
8 Dec 2021
SULIMAN SHEHNAAZ President and COO
Sold, plan not stated 2×
$1.71M 75,000 at 22.79
42.2%
1 Dec 2021
King Robert Chief Development Officer
Sold, plan not stated
$5.02K 250 at 20.09
0.0%
11 Nov 2021
Rosenthal Arnon Chief Executive Officer · indirect
Sold, plan not stated
$1.38M 55,000 at 25.00
2.7%
10 Nov 2021
Rosenthal Arnon Chief Executive Officer · indirect
Sold, plan not stated
$1.38M 55,000 at 25.00
2.6%
9 Nov 2021
Rosenthal Arnon Chief Executive Officer · indirect
Sold, plan not stated 4×
$2.50M 100,000 at 25.00
13.3%
8 Nov 2021
Rosenthal Arnon Chief Executive Officer · indirect
Sold, plan not stated 4×
$2.50M 100,000 at 25.00
13.0%
5 Nov 2021
Rosenthal Arnon Chief Executive Officer · indirect
Sold, plan not stated 4×
$2.50M 100,000 at 25.00
12.8%
4 Nov 2021
Rosenthal Arnon Chief Executive Officer · indirect
Sold, plan not stated 4×
$2.50M 100,000 at 25.00
12.5%
23 Sep 2021
Rosenthal Arnon Chief Executive Officer · indirect
Sold, plan not stated
$241.57K 9,625 at 25.10
0.4%
22 Sep 2021
Rosenthal Arnon Chief Executive Officer · indirect
Sold, plan not stated 2×
$2.53M 100,000 at 25.33
4.1%
21 Sep 2021
Rosenthal Arnon Chief Executive Officer · indirect
Sold, plan not stated 2×
$2.61M 100,000 at 26.11
4.0%
20 Sep 2021
Rosenthal Arnon Chief Executive Officer · indirect
Sold, plan not stated 2×
$2.58M 100,000 at 25.80
3.8%
9 Aug 2021
Paul Robert Chief Medical Officer
Sold, plan not stated 2×
$623.77K 22,950 at 27.18
8.9%
5 Aug 2021
Sold, plan not stated 2×
$1.56M 56,260 at 27.68
100%
Sold half or more
7 Jul 2021
Paul Robert Chief Medical Officer
Sold, plan not stated 3×
$1.15M 29,749 at 38.70
11.3%
6 Jul 2021
Paul Robert Chief Medical Officer
Sold, plan not stated 6×
$1.12M 30,000 at 37.31
11.3%
6 Jul 2021
Yu Calvin Vice President, Finance
Sold, plan not stated
$115.52K 3,334 at 34.65
4.2%
2 Jul 2021
Yu Calvin Vice President, Finance
Sold, plan not stated 2×
$3.63M 110,840 at 32.74
59.1%
Sold half or more
2 Jul 2021
King Robert Chief Development Officer
Sold, plan not stated
$1.87M 60,000 at 31.14
10.3%
2 Jul 2021
Paul Robert Chief Medical Officer
Sold, plan not stated
$934.20K 30,000 at 31.14
11.3%
Showing 51–100 of 180. ← Newer Page 2 of 4 Older →